#BEGIN_DRUGCARD DB06960

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C20H39NO3

# Chemical_IUPAC_Name:
N-[(2R,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]acetamide

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:18:02 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
N-[(1R,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]acetamide

# HET_ID:
2ED

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C20H39NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20(24)19(17-22)21-18(2)23/h15-16,19-20,22,24H,3-14,17H2,1-2H3,(H,21,23)/b16-15+/t19-,20-/m1/s1

# InChI_Key:
InChIKey=BLTCBVOJNNKFKC-KTEGJIGUSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
6966

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
341.5286

# Molecular_Weight_Mono:
341.292994119

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
5.27

# Predicted_LogS:
-5.1

# Predicted_Water_Solubility:
2.96e-03 g/l

# Primary_Accession_No:
DB06960

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
12302745

# PubChem_Substance_ID:
99443431

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@@](O)(\C=C\CCCCCCCCCCCCC)[C@@]([H])(CO)NC(C)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:25:03 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted (Potential)

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AB028646

# Drug_Target_1_GenBank_ID_Protein:
6594292

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
PA0845

# Drug_Target_1_Gene_Sequence:
>2013 bp
ATGTCACGTTCCGCATTCACCGCGCTCTTGCTGTCCTGCGTCCTGCTGGCGCTCTCCATG
CCTGCCAGGGCCGACGACCTGCCCTACCGCTTCGGCCTGGGCAAGGCGGACATCACCGGC
GAAGCCGCCGAAGTCGGCATGATGGGTTACTCCTCCCTCGAACAGAAGACCGCCGGCATC
CACATGCGCCAGTGGGCGCGTGCCTTCGTGATCGAGGAAGCGGCCAGCGGACGTCGCCTG
GTCTACGTCAACACCGACCTGGGGATGACCTTCCAGGCCGTGCACCTGAAGGTCCTGGCC
CGGCTCAAGGCGAAGTACCCCGGTGTCTACGACGAGAACAACGTGATGCTCGCCGCCACC
CACACCCACTCCGGTCCGGGCGGCTTCTCCCACTACGCGATGTACAACCTGTCGGTGCTC
GGCTTCCAGGAAAAGACCTTCAACGCCATCGTCGACGGCATCGTCCGCTCCATCGAGCGG
GCCCAGGCCAGGTTGCAGCCCGGCCGCCTGTTCTACGGCAGCGGCGAGCTGCGCAACGCC
AGCCGCAACCGTTCGCTGCTGTCGCACCTGAAGAATCCGGACATCGCCGGCTACGAGGAT
GGCATCGACCCGCAGATGAGCGTGCTCAGCTTCGTCGACGCCAACGGCGAGCTGGCCGGC
GCGATCAGTTGGTTCCCGGTGCACAGCACCTCGATGACCAACGCCAATCACCTGATCTCC
CCGGACAACAAGGGCTACGCCTCCTATCACTGGGAGCACGACGTCAGCCGCAAGAGCGGT
TTCGTCGCCGCCTTCGCCCAGACCAATGCCGGCAACCTGTCGCCCAACCTGAACCTGAAG
CCCGGCTCCGGTCCCTTCGACAACGAGTTCGACAACACCCGCGAGATCGGTCTGCGCCAA
TTCGCCAAGGCCTACGAGATCGCCGGCCAGGCCCAGGAGGAAGTGCTCGGCGAACTGGAT
TCGCGCTTCCGTTTCGTCGACTTCACCCGCCTGCCGATCCGCCCGGAGTTCACCGACGGC
CAGCCGCGCCAGTTGTGCACCGCGGCCATCGGCACCAGCCTGGCCGCCGGTAGCACCGAA
GACGGTCCAGGCCCGCTGGGGCTGGAGGAAGGCAACAATCCGTTCCTCTCGGCCCTTGGC
GGGTTGCTCACCGGCGTGCCGCCGCAGGAACTGGTGCAATGCCAGGCGGAAAAGACCATC
CTCGCCGACACCGGCAACAAGAAACCCTACCCCTGGACGCCGACGGTGCTGCCGATCCAG
ATGTTCCGCATCGGCCAGTTGGAACTGCTCGGCGCCCCCGCCGAGTTCACCGTGATGGCC
GGGGTGCGGATCCGCCGCGCGGTGCAGGCGGCCAGCGAAGCGGCCGGTATCCGCCATGTG
GTCTTCAATGGCTACGCGAATGCCTATGCCAGCTACGTCACCACCCGCGAGGAATACGCC
GCCCAGGAATACGAAGGCGGCTCGACCCTCTACGGCCCCTGGACCCAGGCCGCCTACCAG
CAGTTGTTCGTCGACATGGCGGTGGCGCTGCGCGAACGCCTGCCGGTGGAAACCTCGGCG
ATAGCGCCGGACCTGTCCTGCTGCCAGATGAACTTCCAGACCGGAGTAGTGGCCGATGAT
CCCTATATCGGCAAGTCCTTCGGCGACGTGTTGCAACAACCCAGGGAAAGTTATCGCATC
GGCGACAAGGTGACCGTCGCTTTCGTGACCGGACATCCGAAGAATGACTTGCGCACCGAG
AAGACTTTCCTGGAAGTGGTGAATATCGGCAAGGATGGCAAACAGACGCCCGTGACCGTT
GCCACCGATAATGACTGGGATACCCAATACCGCTGGGAGAGAGTGGGTATATCTGCCTCG
AAAGCGACTATCAGCTGGTCCATTCCACCAGGGACCGAGCCCGGCCATTACTACATCAGG
CACTATGGCAACGCGAAGAACTTCTGGACCCAGAAGATCAGCGAAATCGGCGGCTCGACC
CGCTCCTTCGAGGTGCTCGGCACCACTCCCTAG

# Drug_Target_1_General_Function:
Involved in ceramidase activity

# Drug_Target_1_General_References:
10593963	Okino N, Ichinose S, Omori A, Imayama S, Nakamura T, Ito M: Molecular cloning, sequencing, and expression of the gene encoding alkaline ceramidase from Pseudomonas aeruginosa. Cloning of a ceramidase homologue from Mycobacterium tuberculosis. J Biol Chem. 1999 Dec 17;274(51):36616-22.
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
11879188	Kita K, Sueyoshi N, Okino N, Inagaki M, Ishida H, Kiso M, Imayama S, Nakamura T, Ito M: Activation of bacterial ceramidase by anionic glycerophospholipids: possible involvement in ceramide hydrolysis on atopic skin by Pseudomonas ceramidase. Biochem J. 2002 Mar 15;362(Pt 3):619-26.
12821326	Nieuwenhuizen WF, van Leeuwen S, Jack RW, Egmond MR, Gotz F: Molecular cloning and characterization of the alkaline ceramidase from Pseudomonas aeruginosa PA01. Protein Expr Purif. 2003 Jul;30(1):94-104.
15123644	Tani M, Okino N, Sueyoshi N, Ito M: Conserved amino acid residues in the COOH-terminal tail are indispensable for the correct folding and localization and enzyme activity of neutral ceramidase. J Biol Chem. 2004 Jul 9;279(28):29351-8. Epub 2004 May 3.
9603946	Okino N, Tani M, Imayama S, Ito M: Purification and characterization of a novel ceramidase from Pseudomonas aeruginosa. J Biol Chem. 1998 Jun 5;273(23):14368-73.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
6265

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
73372.1

# Drug_Target_1_Name:
Neutral ceramidase

# Drug_Target_1_Number_of_Residues:
670

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF04734	Ceramidase_alk

# Drug_Target_1_Protein_Sequence:
>Neutral ceramidase
MSRSAFTALLLSCVLLALSMPARADDLPYRFGLGKADITGEAAEVGMMGYSSLEQKTAGI
HMRQWARAFVIEEAASGRRLVYVNTDLGMIFQAVHLKVLARLKAKYPGVYDENNVMLAAT
HTHSGPGGFSHYAMYNLSVLGFQEKTFNAIVDGIVRSIERAQARLQPGRLFYGSGELRNA
NRNRSLLSHLKNPDIVGYEDGIDPQMSVLSFVDANGELAGAISWFPVHSTSMTNANHLIS
PDNKGYASYHWEHDVSRKSGFVAAFAQTNAGNLSPNLNLKPGSGPFDNEFDNTREIGLRQ
FAKAYEIAGQAQEEVLGELDSRFRFVDFTRLPIRPEFTDGQPRQLCTAAIGTSLAAGSTE
DGPGPLGLEEGNNPFLSALGGLLTGVPPQELVQCQAEKTILADTGNKKPYPWTPTVLPIQ
MFRIGQLELLGAPAEFTVMAGVRIRRAVQAASEAAGIRHVVFNGYANAYASYVTTREEYA
AQEYEGGSTLYGPWTQAAYQQLFVDMAVALRERLPVETSAIAPDLSCCQMNFQTGVVADD
PYIGKSFGDVLQQPRESYRIGDKVTVAFVTGHPKNDLRTEKTFLEVVNIGKDGKQTPETV
ATDNDWDTQYRWERVGISASKATISWSIPPGTEPGHYYIRHYGNAKNFWTQKISEIGGST
RSFEVLGTTP

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-24

# Drug_Target_1_Specific_Function:
Hydrolyzes the ceramides into sphingosine and free fatty acid at an optimal pH of 8-9

# Drug_Target_1_SwissProt_ID:
Q9I596

# Drug_Target_1_SwissProt_Name:
NCASE_PSEAE

# Drug_Target_1_Synonyms:
Acylsphingosine deacylase
N-CDase
N-acylsphingosine amidohydrolase
NCDase

# Drug_Target_1_Theoretical_pI:
6.17

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB06960
